Trials / Completed
CompletedNCT01194713
Effects of Sleep Deprivation on Cerebrospinal Fluid (CSF) Amyloid-beta (Aβ) Dynamics
Losing Sleep Over Alzheimer's Disease? Effects of Sleep Deprivation on Cerebrospinal Fluid Amyloid-beta Dynamics
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- University Medical Center Nijmegen · Academic / Other
- Sex
- Male
- Age
- 40 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Introduction: Alzheimer's disease (AD) is characterized by neurodegeneration of the brain in the form of neurofibrillary tangles and plaques containing the amyloid-beta protein (Abeta). Recent animal studies have shown that extended wakefulness is associated with increased production of these Abeta proteins and that sleep leads to a marked fall in their production. Aim: The investigators aim to distinguish a similar effect of sleep disturbance on cerebrospinal fluid (CSF) Abeta levels in humans, which may point out sleep disturbance as an important factor in AD development. Methods: a study in 26 healthy male volunteers, measuring CSF Abeta levels during a sleep deprivation night and before and after a control night with unrestricted sleep. Expected results: The investigators expect sleep deprivation to lead to an increase in CSF Abeta levels, as compared to the levels in the control night.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Sleep deprivation | subjects will undergo one night of full sleep deprivation |
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2013-09-01
- Completion
- 2013-09-01
- First posted
- 2010-09-03
- Last updated
- 2014-05-13
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT01194713. Inclusion in this directory is not an endorsement.